- The prevalence of chronic pain among cancer survivors appears high and is likely to increase with use of multiple therapies having additive or synergistic long-term toxicity.
Why this matters
- "These findings underscore the need to raise awareness regarding the multifaceted pain experience of cancer survivors and to train providers in screening for and managing chronic pain," researchers say.
- 115,091 U.S. participants (no cancer history, n=107,526; cancer history, n=7565) from the National Health Interview Survey were studied.
- Funding: None disclosed.
- Higher odds for chronic pain were noted in participants with a history of cancer diagnosis than without (30.8% vs 15.7%; aOR, 1.48; P<.001>
- Positive association between older age (≥48 years) and chronic pain was limited to patients without cancer (aOR, 2.38; P<.001>
- History of sarcoma was tied to the highest odds for cancer pain (aOR, 2.62; 95% CI, 1.67-4.13).
- In participants with a history of cancer diagnosis, chronic pain was associated with greater odds (P<.001 for:>
- Feeling depressed (aOR, 3.49).
- Feeling worried/nervous/anxious (aOR, 2.60).
- Missed work (aOR, 4.90).
- Assistance needed for activities of daily living (aOR, 3.92).
- Instrumental activities of daily living (aOR, 3.86).
- Cross-sectional survey without follow-up.
Coauthored with Chitra Ravi, MPharm